Common stock only | |
S&P 500 only | |
Director Only | |
10% Owner Only |
Trans Codes
Select...
Amount
-
Trade TCMD Insider Trades:
all
Unusual
Whales
Unusual Whales
Unusual Whales
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-05-12
2025-05-14
BIRKEMEYER ELAINE
Chief Financial Officer
S - Sale
Common Stock
-2,921
$10.00
-29,210
1
$219M
2025-05-08
2025-05-12
DODD SHERI LOUISE
Chief Executive Officer
S - Sale
Common Stock
-3,149
$10.00
-31,490
1
$219M
2025-02-25
2025-02-27
BIRKEMEYER ELAINE
Chief Financial Officer
S - Sale
Common Stock
-2,066
$15.00
-30,990
1
$219M
2025-02-25
2025-02-27
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
S - Sale
Common Stock
-6,468
$14.00
-90,552
1
$219M
2025-02-24
2025-02-24
BIRKEMEYER ELAINE
Chief Financial Officer
S - Sale
Common Stock
-3,778
$15.00
-56,670
1
$219M
2025-02-24
2025-02-24
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
S - Sale
Common Stock
-4,830
$15.00
-72,450
1
$219M
2025-02-20
2025-02-24
BIRKEMEYER ELAINE
Chief Financial Officer
A - Grant
Common Stock
46,581
$0.00
3
$219M
2025-02-20
2025-02-24
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
A - Grant
Common Stock
24,069
$0.00
3
$219M
2025-02-20
2025-02-24
DODD SHERI LOUISE
Chief Executive Officer
A - Grant
Common Stock
85,777
$0.00
2
$219M
2024-08-12
2024-08-14
FERSTLER SHERRI LEE
Senior VP, Sales
S - Sale
Common Stock
-1,550
$13.00
-20,150
1
$219M
2024-08-07
2024-08-09
DODD SHERI LOUISE
Chief Executive Officer
A - Grant
Common Stock
64,959
$0.00
1
$219M
2024-05-16
2024-05-20
BIRKEMEYER ELAINE
Chief Financial Officer
S - Sale
Common Stock
-3,041
$14.00
-42,574
1
$219M
2024-05-06
2024-05-08
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
S - Sale
Common Stock
-815
$14.00
-11,410
1
$219M
2024-02-29
2024-02-29
REUVERS DANIEL
President and CEO
S - Sale
Common Stock
-1,396
$15.00
-20,940
1
$219M
2024-02-29
2024-02-29
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
S - Sale
Common Stock
-243
$15.00
-3,645
1
$219M
2024-02-27
2024-02-29
REUVERS DANIEL
President and CEO
S - Sale
Common Stock
-4,689
$16.00
-75,024
1
$219M
2024-02-27
2024-02-29
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
S - Sale
Common Stock
-1,091
$16.00
-17,456
1
$219M
2024-02-26
2024-02-27
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
S - Sale
Common Stock
-2,015
$16.00
-32,240
1
$219M
2024-02-26
2024-02-27
REUVERS DANIEL
President and CEO
S - Sale
Common Stock
-6,239
$16.00
-99,824
1
$219M
2024-02-24
2024-02-27
BIRKEMEYER ELAINE
Chief Financial Officer
A - Grant
Common Stock
2,848
$0.00
1
$219M
2024-02-24
2024-02-27
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
A - Grant
Common Stock
11,762
$0.00
2
$219M
2024-02-23
2024-02-27
REUVERS DANIEL
President and CEO
S - Sale
Common Stock
-5,378
$15.00
-80,670
1
$219M
2024-02-23
2024-02-27
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
S - Sale
Common Stock
-2,249
$15.00
-33,735
1
$219M
2024-02-21
2024-02-23
BIRKEMEYER ELAINE
Chief Financial Officer
A - Grant
Common Stock
32,420
$0.00
1
$219M
2024-02-21
2024-02-23
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
A - Grant
Common Stock
19,452
$0.00
1
$219M
2023-08-07
2023-08-09
REUVERS DANIEL
President and CEO
S - Sale
Common Stock
-1,062
$21.00
-22,302
1
$219M
2023-05-10
2023-05-11
BIRKEMEYER ELAINE
Chief Financial Officer
A - Grant
Common Stock
29,068
$0.00
1
$219M
2023-05-08
2023-05-10
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
S - Sale
Common Stock
-786
$19.00
-14,934
1
$219M
2023-03-01
2023-03-03
MOEN BRENT
Chief Financial Officer
S - Sale
Common Stock
-1,391
$14.00
-19,474
1
$219M
2023-02-28
2023-02-28
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
S - Sale
Common Stock
-135
$15.00
-2,025
1
$219M
2023-02-27
2023-02-28
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
S - Sale
Common Stock
-2,162
$15.00
-32,430
1
$219M
2023-02-27
2023-02-28
MOEN BRENT
Chief Financial Officer
S - Sale
Common Stock
-3,801
$15.00
-57,015
1
$219M
2023-02-27
2023-02-28
REUVERS DANIEL
President and CEO
S - Sale
Common Stock
-6,387
$15.00
-95,805
1
$219M
2023-02-25
2023-02-28
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
A - Grant
Common Stock
962
$0.00
1
$219M
2023-02-22
2023-02-24
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
A - Grant
Common Stock
16,724
$0.00
1
$219M
2022-05-06
2022-05-10
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
S - Sale
Common Stock
-999
$13.00
-12,987
1
$219M
2022-03-01
2022-03-03
MOEN BRENT
Chief Financial Officer
S - Sale
Common Stock
-1,632
$20.00
-32,640
1
$219M
2022-02-28
2022-02-28
MOEN BRENT
Chief Financial Officer
S - Sale
Common Stock
-624
$20.00
-12,480
1
$219M
2022-02-24
2022-02-28
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
A - Grant
Common Stock
16,181
$0.00
1
$219M
2021-10-01
2021-10-05
ROCHE KEVIN
M - Exercise
Employee Stock Option (right to buy)
-25,755
$0.00
3
$219M
2021-08-06
2021-08-09
REUVERS DANIEL
President and CEO
S - Sale
Common Stock
-1,063
$43.00
-45,709
1
$219M
2021-05-05
2021-05-07
PAULS ERIC
Senior VP, Sales
A - Grant
Employee Stock Option (right to buy)
3,153
$0.00
1
$219M
2021-05-05
2021-05-07
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
A - Grant
Employee Stock Option (right to buy)
5,094
$0.00
1
$219M
2021-05-05
2021-05-07
BURNS KRISTIE
Sr. VP Mktg & Clinical Affairs
A - Grant
Common Stock
6,777
$0.00
2
$219M
2021-02-28
2021-03-02
MOEN BRENT
Chief Financial Officer
S - Sale
Common Stock
-1,429
$51.00
-72,879
1
$219M
2021-02-25
2021-03-02
RISHE BRYAN
SVP, Sales
A - Grant
Employee Stock Option (right to buy)
6,053
$0.00
1
$219M
2021-02-25
2021-03-02
MOEN BRENT
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
13,835
$0.00
1
$219M
2021-02-25
2021-03-02
REUVERS DANIEL
President and CEO
A - Grant
Employee Stock Option (right to buy)
19,456
$0.00
1
$219M
2020-08-05
2020-08-07
REUVERS DANIEL
President and CEO
A - Grant
Employee Stock Option (right to buy)
51,028
$0.00
2
$219M
2020-04-29
2020-04-30
MATTYS GERALD
Chief Executive Officer
S - Sale
Common Stock
-39,900
$56.00
-2.23M
2
$219M
2020-04-29
2020-04-30
MATTYS GERALD
Chief Executive Officer
M - Exercise
Stock Option (right to buy)
-93,002
$0.00
1
$219M
2020-04-29
2020-04-30
MATTYS GERALD
Chief Executive Officer
M - Exercise
Common Stock
93,002
$1.00
93,002
1
$219M
2020-04-28
2020-04-30
MATTYS GERALD
Chief Executive Officer
S - Sale
Common Stock
-100
$55.00
-5,500
1
$219M
2020-02-28
2020-03-13
FOLKES ROBERT
Chief Operating Officer
F - Tax
Common Stock
-315
$50.00
-15,750
1
$219M
2020-02-28
2020-03-13
MATTYS GERALD
Chief Executive Officer
F - Tax
Common Stock
-826
$50.00
-41,300
1
$219M
2020-03-05
2020-03-09
FOLKES ROBERT
Chief Operating Officer
S - Sale
Common Stock
-180
$49.00
-8,820
1
$219M
2020-03-05
2020-03-09
MATTYS GERALD
Chief Executive Officer
S - Sale
Common Stock
-560
$48.00
-26,880
1
$219M
2020-02-28
2020-03-03
FOLKES ROBERT
Chief Operating Officer
A - Grant
Employee Stock Option (right to buy)
7,151
$0.00
1
$219M
2020-02-28
2020-03-03
MOEN BRENT
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
14,303
$0.00
1
$219M
2020-02-28
2020-03-03
RISHE BRYAN
SVP, Sales
A - Grant
Employee Stock Option (right to buy)
7,151
$0.00
1
$219M
2020-02-26
2020-02-28
FOLKES ROBERT
Chief Operating Officer
F - Tax
Common Stock
-876
$54.00
-47,304
1
$219M
2020-02-26
2020-02-28
MATTYS GERALD
Chief Executive Officer
F - Tax
Common Stock
-2,360
$54.00
-127K
1
$219M
2020-02-20
2020-02-24
FOLKES ROBERT
Chief Operating Officer
S - Sale
Common Stock
-2,106
$64.00
-135K
1
$219M
2020-02-06
2020-02-10
FOLKES ROBERT
Chief Operating Officer
S - Sale
Common Stock
-2,106
$59.00
-124K
1
$219M
2020-01-23
2020-01-27
FOLKES ROBERT
Chief Operating Officer
S - Sale
Common Stock
-2,106
$57.00
-120K
1
$219M
2020-01-09
2020-01-13
FOLKES ROBERT
Chief Operating Officer
S - Sale
Common Stock
-2,106
$68.00
-143K
1
$219M
2019-12-31
2020-01-03
MATTYS GERALD
Chief Executive Officer
M - Exercise
Employee Stock Option (right to buy)
-25,000
$0.00
1
$219M
2019-12-31
2020-01-03
MATTYS GERALD
Chief Executive Officer
M - Exercise
Common Stock
25,000
$1.00
25,000
1
$219M
2019-12-26
2019-12-27
FOLKES ROBERT
Chief Operating Officer
S - Sale
Common Stock
-2,106
$70.00
-147K
3
$219M
2019-12-26
2019-12-26
RISHE BRYAN
SVP, Sales
M - Exercise
Employee Stock Option (right to buy)
-4,812
$0.00
1
$219M
2019-12-23
2019-12-26
RISHE BRYAN
SVP, Sales
M - Exercise
Employee Stock Option (right to buy)
-3,409
$0.00
1
$219M
2019-12-23
2019-12-26
MATTYS GERALD
Chief Executive Officer
S - Sale
Common Stock
-30,000
$70.00
-2.10M
1
$219M